Antimicrobial polymer compositions

• US 4,479,795 A
• Filed: 07/27/1982
• Issued: 10/30/1984
• Est. Priority Date: 06/29/1979
• Status: Expired due to Fees

• Current Assignee: The Procter & Gamble Company
• Original Assignee: The Procter & Gamble Company
• Inventors: Mustacich, Robert V., Stone, Roger L., Lucas, Donald S.
• Primary Examiner(s): Padgett, Benjamin R.
• Assistant Examiner(s): Wallen, T. J.
• Application Number:
  US06/402,381
• Time in Patent Office: 826 Days
• Field of Search: 604/265, 604/890-897, 604/51-53, 424/19-26
• US Class Current: 604/500
• CPC Class Codes: A01N 2300/00 Combinations or mixtures of active ingredients covered by classes A01N27/00 - A01N65/48 with other active or formulation relevant ingredients, e.g. specific carrier materials or surfactants, covered by classes A01N25/00 - A01N65/48
• CPC Class Codes: A01N 37/02 Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
• CPC Class Codes: A01N 37/06 Unsaturated carboxylic acids or thio analogues thereof; Derivatives thereof
• CPC Class Codes: A61L 15/46 Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
• CPC Class Codes: A61L 2300/21 Acids
• CPC Class Codes: A61L 2300/404 Biocides, antimicrobial agents, antiseptic agents
• CPC Class Codes: A61L 29/16 Biologically active materials, e.g. therapeutic substances A61L29/048 takes precedence

Abstract

The present invention relates to medical polymers and devices made therefrom, and is based on the discovery that certain carboxylate antimicrobial agents can be releasably incorporated into permeable polymers. The walls of medical devices such as catheters can be fashioned from such polymers. In use, the antimicrobial agent diffuses from the walls to the surface of the device to form an antimicrobial barrier on the surface of the device and a zone of microbial inhibition on tissue surfaces surrounding the device, thereby effectively supplementing the body'"'"'s own natural microbial barriers where they have been compromised. The bacterial contamination-resistant carboxylate-plus-polymer compositions herein can be used in the manufacture of a wide variety of medical devices, especially urinary catheters, intravenous catheters, wound dressings, and the like.

Claims

1. A method for catheterization of humans and lower animals with lowered risk of nosocomial infection by achieving microbial inhibition at and around the placement site of catheters and the like used in the bodies of humans and lower animals, comprising:

inserting into the body of a human or lower animal in need of such treatment a catheter, or the like, said catheter comprising;

delivery means for transporting liquid materials, said delivery means being in the form of a tube;

at least part of the portion of said tube which contacts the body comprising a toxicologically-acceptable, medical-grade elastomeric polymer, said polymer having releasably incorporated within the polymer matrix a safe and effective amount of one or more free n-alkane monocarboxylic acid antimicrobial agents or salts thereof, having from about 4 to about 10 carbon atoms, said polymer containing from about 0.1% to about 40% by weight of a substantially non-antimicrobial proton donor selected from the group consisting of citric acid, tartaric acid, malic acid, fumaric acid, maleic acid, malonic acid, ascorbic acid, barbituric acid, and mixtures thereof.

2. A method according to claim 1 wherein the carboxylate antimicrobial agent is in the form of the protonated acid and comprises from about 0.01% to about 60% by weight of the composition.

3. A method according to claim 1 wherein the antimicrobial agent is in the form of a pharmaceutically-acceptable salt and comprises from about 0.01% to about 60% by weight of the composition.

4. A method according to claim 1 wherein the carboxylate antimicrobial agent is a C₆ -C₁₀ n-alkane carboxylate.

5. A method according to claim 4 wherein the antimicrobial agent is selected from the group consisting of octanoic acid, sodium octanoate, and mixtures thereof.

6. A method according to claim 5 wherein the antimicrobial agent is selected from the group consisting of decanoic acid, sodium decanoate, and mixtures thereof.

7. A method according to claim 1 wherein the antimicrobial agent is in the form of one or more pharmaceutically-acceptable alkali metal salts of the n-alkane monocarboxylic acids.

8. A method according to claim 7, wherein the antimicrobial agent is in the form of one or more pharmaceutically-acceptable alkali metal salts of the n-alkane monocarboxylic acids.